|
1
|
Soriano JB, Murthy S, Marshall JC, Relan P
and Diaz JV: WHO Clinical Case Definition Working Group On
Post-COVID-19 Condition. A clinical case definition of
post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis.
22:e102–e107. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Davis HE, McCorkell L, Vogel JM and Topol
EJ: Long COVID: Major findings, mechanisms and recommendations. Nat
Rev Microbiol. 21:133–146. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lopez-Leon S, Wegman-Ostrosky T, Perelman
C, Sepulveda R, Rebolledo PA, Cuapio A and Villapol S: More than 50
long-term effects of COVID-19: A systematic review and
meta-analysis. Sci Rep. 11(16144)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sugiyama A, Miwata K, Kitahara Y, Okimoto
M, Abe K, Bunthen E, Ouoba S, Akita T, Tanimine N, Ohdan H, et al:
Long COVID occurrence in COVID-19 survivors. Sci Rep.
12(6039)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Miyazato Y, Tsuzuki S, Morioka S, Terada
M, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Akashi
M, et al: Factors associated with development and persistence of
post-COVID conditions: A cross-sectional study. J Infect Chemother.
28:1242–1248. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Woodrow M, Carey C, Ziauddeen N, Thomas R,
Akrami A, Lutje V, Greenwood DC and Alwan NA: Systematic review of
the prevalence of long COVID. Open Forum Infect Dis.
10(ofad233)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Han Q, Zheng B, Daines L and Sheikh A:
Long-term sequelae of COVID-19: A systematic review and
meta-analysis of one-year follow-up studies on post-COVID symptoms.
Pathogens. 11(269)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Morioka S, Tsuzuki S, Maruki T, Terada M,
Miyazato Y, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada
M, et al: Epidemiology of post-COVID conditions beyond 1 year: A
cross-sectional study. Public Health. 216:39–44. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Imoto W, Yamada K, Kawai R, Imai T,
Kawamoto K, Uji M, Kanda H, Takada M, Ohno Y, Ohtani H, et al: A
cross-sectional, multicenter survey of the prevalence and risk
factors for Long COVID. Sci Rep. 12(22413)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Perumal R, Shunmugam L, Naidoo K, Karim
SS, Wilkins D, Garzino-Demo A, Brechot C, Parthasarathy S, Vahlne A
and Nikolich JŽ: Long COVID: A review and proposed visualization of
the complexity of long COVID. Front Immunol.
14(1117464)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morioka S, Tsuzuki S, Suzuki M, Terada M,
Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, et al:
Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J
Infect Chemother. 28:1546–1551. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Srikanth S, Boulos JR, Dover T, Boccuto L
and Dean D: Identification and diagnosis of long COVID-19: A
scoping review. Prog Biophys Mol Biol. 182:1–7. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kutsuna S, Onozuka D, Asano K, Matsunami K
and Matsuoka T: Cross-sectional surveillance study of long COVID in
Toyonaka city, Osaka prefecture, Japan. J Infect Chemother.
30:511–515. 2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khanh HN, Cornelissen L,
Castanares-Zapatero D, De Pauw R, Van Cauteren D, Demarest S,
Drieskens S, Devleesschauwer B, De Ridder K, Charafeddine R and
Smith P: Association between SARS-CoV-2 variants and post COVID-19
condition: Findings from a longitudinal cohort study in the Belgian
adult population. BMC Infect Dis. 23(774)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fernández-de-Las-Peñas C, Notarte KI,
Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L,
Torres-Macho J and Plaza-Manzano G: Long-COVID symptoms in
individuals infected with different SARS-CoV-2 variants of concern:
A systematic review of the literature. Viruses.
14(2629)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cai J, Lin K, Zhang H, Xue Q, Zhu K, Yuan
G, Sun Y, Zhu F, Ai J, Wang S and Zhang W: A one-year follow-up
study of systematic impact of long COVID symptoms among patients
post SARS-CoV-2 omicron variants infection in Shanghai, China.
Emerg Microbes Infect. 12(2220578)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kodera S, Niimi Y, Rashed EA, Yoshinaga N,
Toyoda M and Hirata A: Estimation of mRNA COVID-19 vaccination
effectiveness in Tokyo for Omicron variants BA.2 and BA.5: Effect
of social behavior. Vaccines (Basel). 10(1820)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nakano Y, Otsuka Y, Honda H, Sunada N,
Tokumasu K, Sakurada Y, Matsuda Y, Hasegawa T, Ochi K, Hagiya H, et
al: Transitional changes in fatigue-related symptoms due to long
COVID: A single-center retrospective observational study in Japan.
Medicina (Kaunas). 58(1393)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Menni C, Valdes AM, Polidori L, Antonelli
M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, et
al: Symptom prevalence, duration, and risk of hospital admission in
individuals infected with SARS-CoV-2 during periods of omicron and
delta variant dominance: A prospective observational study from the
ZOE COVID Study. Lancet. 399:1618–1624. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Torjesen I: Covid-19: Omicron may be more
transmissible than other variants and partly resistant to existing
vaccines, scientists fear. BMJ. 375(n2943)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Michelen M, Manoharan L, Elkheir N, Cheng
V, Dagens A, Hastie C, O'Hara M, Suett J, Dahmash D, Bugaeva P, et
al: Characterising long COVID: A living systematic review. BMJ Glob
Health. 6(e005427)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Surapaneni KM, Singhal M, Saggu SR, Bhatt
A, Shunmathy P and Joshi A: A scoping review on long COVID-19:
Physiological and psychological symptoms post-acute, long-post and
persistent post COVID-19. Healthcare (Basel).
10(2418)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Luo J, Zhang J, Tang HT, Wong HK, Lyu A,
Cheung CH and Bian Z: Prevalence and risk factors of long COVID
6-12 months after infection with the Omicron variant among
nonhospitalized patients in Hong Kong. J Med Virol.
95(e28862)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shang H, Chang T, Yang W, Shi L, Hu S,
Tian L, Ren J, Wang T, Wang J, Guo J and Cui Y: Analysis of
influencing factors on long COVID in COVID-19 patients infected
with omicron variant three months after discharge: A
cross-sectional study. BMC Infect Dis. 24(36)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Neufeld KJ, Leoutsakos JS, Yan H, Lin S,
Zabinski JS, Dinglas VD, Hosey MM, Parker AM, Hopkins RO and
Needham DM: Fatigue symptoms during the first year following ARDS.
Chest. 158:999–1007. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pallanti S, Grassi E, Makris N, Gasic GP
and Hollander E: Neurocovid-19: A clinical neuroscience-based
approach to reduce SARS-CoV-2 related mental health sequelae. J
Psychiatr Res. 130:215–217. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Maglietta G, Diodati F, Puntoni M,
Lazzarelli S, Marcomini B, Patrizi L and Caminiti C: Prognostic
factors for Post-COVID-19 syndrome: A systematic review and
meta-analysis. J Clin Med. 11(1541)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tsampasian V, Elghazaly H, Chattopadhyay
R, Debski M, Naing TKP, Garg P, Clark A, Ntatsaki E and Vassiliou
VS: Risk factors associated with post-COVID-19 condition: A
systematic review and meta-analysis. JAMA Intern Med. 183:566–580.
2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Whitaker M, Elliott J, Chadeau-Hyam M,
Riley S, Darzi A, Cooke G, Ward H and Elliott P: Persistent
COVID-19 symptoms in a community study of 606,434 people in
England. Nat Commun. 13(1957)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamamoto A, Wada H, Ichikawa Y, Mizuno H,
Tomida M, Masuda J, Makino K, Kodama S, Yoshida M, Fukui S, et al:
Evaluation of biomarkers of severity in patients with COVID-19
infection. J Clin Med. 10(3775)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wada H, Shiraki K, Shimpo H, Shimaoka M,
Iba T and Suzuki-Inoue K: Thrombotic mechanism involving platelet
activation, hypercoagulability and hypofibrinolysis in coronavirus
disease 2019. Int J Mol Sci. 24(7975)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Matsunaga A, Tsuzuki S, Morioka S,
Ohmagari N and Ishizaka Y: Long COVID: current status in Japan and
knowledge about its molecular background. Glob Health Med. 4:83–93.
2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ding Q and Zhao H: Long-term effects of
SARS-CoV-2 infection on human brain and memory. Cell Death Discov.
9(196)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Notarte KI, Catahay JA, Velasco JV,
Pastrana A, Ver AT, Pangilinan FC, Peligro PJ, Casimiro M, Guerrero
JJ, Gellaco MML, et al: Impact of COVID-19 vaccination on the risk
of developing long-COVID and on existing long-COVID symptoms: A
systematic review. EClinicalMedicine. 53(101624)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gao P, Liu J and Liu M: Effect of COVID-19
vaccines on reducing the risk of long COVID in the real world: A
systematic review and meta-analysis. Int J Environ Res Public
Health. 19(12422)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Xie Y, Choi T and Al-Aly Z: Association of
treatment with Nirmatrelvir and the risk of post-COVID-19
condition. JAMA Intern Med. 183:554–564. 2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Choi YJ, Seo YB, Seo JW, Lee J, Nham E,
Seong H, Yoon JG, Noh JY, Cheong HJ, Kim WJ, et al: Effectiveness
of antiviral therapy on long COVID: A systematic review and
meta-analysis. J Clin Med. 12(7375)2023.PubMed/NCBI View Article : Google Scholar
|
